首页> 外文期刊>Pain Physician >Effectiveness and Impact of Capsaicin 8% Patch on Quality of Life in Patients with Lumbosacral Pain: An Open-label Study
【24h】

Effectiveness and Impact of Capsaicin 8% Patch on Quality of Life in Patients with Lumbosacral Pain: An Open-label Study

机译:辣椒素8%贴剂对腰ac部疼痛患者生活质量的有效性和影响:一项开放标签研究

获取原文
       

摘要

Capsaicin 8% patch (Qutenza?) is mainly used to treat postherpetic neuralgia and HIV-associated neuropathy. Evidence of the efficacy of Qutenza in other forms of neuropathic pain is lacking. OBJECTIVE: To evaluate the analgesic effect and the impact on quality of life after a single application of the capsaicin 8% cutaneous patch in patients with lumbosacral pain.STUDY DESIGN: Prospective open-label study of capsaicin 8% patch in patients with lumbosacral pain.SETTING: Outpatient Pain and Palliative Care Center.METHODS: All recruited patients were evaluated prior to capsaicin 8% patch administration and were followed-up at 2 weeks, at 8 weeks, and at 12 weeks post administration. Visual analog scale (VAS) was used to record pain intensity and EQ-5D was used to assess the quality of life of the participants.RESULTS: Ninety patients met our inclusion criteria (54.4% men, mean age 59.1 ± 9.2 years). At baseline the mean VAS score of the participants was 7.6 ± 0.7. A statistically significant reduction of the VAS score between baseline and week 2 (mean VAS score 5.6 ± 1.1, P < 0.001) was observed. The therapeutic effect further continued between week 2 and week 8 (mean VAS score 3.2 ± 1.2, P < 0.001) and between week 8 and at endpoint at week 12 (mean VAS score 2.6 ± 1.1, P < 0.001).Between baseline and weeks 2, 8, and 12 (end-point) a significant improvement in all 5 dimensions of EQ-5D (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) was observed (P < 0.001)LIMITATIONS: As it is an open-label study, a prospective randomized placebo-controlled study should be designed to confirm the effectiveness of capsaicin 8% patch in patients with lumbosacral pain.CONCLUSIONS: Administration of the capsaicin 8% patch resulted in a significant relief of neuropathic pain and a significant improvement of the quality of life of patients with lumbosacral neuropathic pain.Key words: Lumbosacral pain, peripheral pain, Qutenza, neuropathic pain, capsaicin, patch, quality of life, effectiveness
机译:辣椒素8%贴剂(Qutenza?)主要用于治疗疱疹后神经痛和与HIV相关的神经病。缺乏Qutenza在其他形式的神经性疼痛中功效的证据。目的:评估腰s部疼痛患者单次应用辣椒素8%皮肤贴剂后的镇痛效果及其对生活质量的影响。研究设计:对腰s部疼痛患者进行辣椒素8%贴剂的前瞻性开放标签研究。地点:门诊疼痛和姑息治疗中心方法:所有募集的患者在给予辣椒素8%贴剂之前接受评估,并在给药后2周,8周和12周进行随访。视觉模拟量表(VAS)用于记录疼痛强度,EQ-5D用于评估参与者的生活质量。结果:90名患者符合我们的纳入标准(男性54.4%,平均年龄59.1±9.2岁)。基线时,参与者的平均VAS评分为7.6±0.7。观察到基线与第2周之间的VAS得分有统计上的显着降低(平均VAS得分5.6±1.1,P <0.001)。在第2周和第8周之间(VAS平均得分3.2±1.2,P <0.001)以及在第8周和第12周终点之间(VAS平均得分2.6±1.1,P <0.001),治疗效果进一步持续。 2、3、8和12(终点)观察到EQ-5D的所有5个方面(运动,自我护理,日常活动,疼痛/不适和焦虑/抑郁)都有显着改善(P <0.001)。由于这是一项开放性研究,因此应设计一项前瞻性随机安慰剂对照研究,以确认辣椒素8%贴剂对腰s部疼痛患者的有效性。结论:辣椒素8%贴剂的使用可显着缓解神经病变腰and神经痛患者的疼痛和生活质量的显着改善。关键词:腰ac部疼痛,周围性疼痛,库琴察,神经性疼痛,辣椒素,贴剂,生活质量,有效性

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号